Thesis

369 References 166. Teirlinck AC, de Gier B, Meijer A, Donker G, de Lange M, Koppeschaar C, et al. The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis. Epidemiol Infect. 2018;147:e30. 167. Reukers DFM, van Asten L, Brandsema PS, Dijkstra F, Hendriksen JMT, Hooiveld M. Surveillance of COVID-19, influenza and other respiratory infections in the Netherlands: winter 2020/2021. RIVM. 2021;0133. 168. Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health. 2013;103(3):e43-51. 169. Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S, et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron. 2023;111(7):1086-93 e2. 170. Zhang XS. Strain Interactions as a Mechanism for Dominant Strain Alternation and Incidence Oscillation in Infectious Diseases: Seasonal Influenza as a Case Study. PLoS One. 2015;10(11):e0142170. 171. Epstein SL, Price GE. Cross-protective immunity to influenza A viruses. Expert Rev Vaccines. 2010;9(11):1325-41. 172. Laurie KL, Carolan LA, Middleton D, Lowther S, Kelso A, Barr IG. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis. 2010;202(7):1011-20. 173. Wilasang C, Suttirat P, Chadsuthi S, Wiratsudakul A, Modchang C. Competitive evolution of H1N1 and H3N2 influenza viruses in the United States: A mathematical modeling study. J Theor Biol. 2022;555:111292. 174. Feltelius N, Persson I, Ahlqvist-Rastad J, Andersson M, Arnheim-Dahlstrom L, Bergman P, et al. A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009-2010 Pandemrix vaccination programme in Sweden. J Intern Med. 2015;278(4):335-53. 175. Van Effelterre T, Dos Santos G, Shinde V. Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010. PLoS One. 2016;11(3):e0151575. 176. de Fougerolles TR, Damm O, Ansaldi F, Chironna M, Crepey P, de Lusignan S, et al. National influenza surveillance systems in five European countries: a qualitative comparative framework based on WHO guidance. BMC Public Health. 2022;22(1):1151. 177. Zanobini P, Bonaccorsi G, Lorini C, Haag M, McGovern I, Paget J, Caini S. Global patterns of seasonal influenza activity, duration of activity and virus (sub)type circulation from 2010 to 2020. Influenza Other Respir Viruses. 2022;16(4):696-706. 178. Liblau RS, Latorre D, Kornum BR, Dauvilliers Y, Mignot EJ. The immunopathogenesis of narcolepsy type 1. Nat Rev Immunol. 2024;24(1):33-48. 179. Trotti LM. Idiopathic Hypersomnia. Sleep Med Clin. 2017;12(3):331-44. 180. Wenz ES, Schinkelshoek MS, Kallweit U, Fronczek R, Rezaei R, Khatami R, et al. Narcolepsy type 1 and Sydenham chorea - Report of 3 cases and review of the literature. Sleep Med. 2023;112:234-8. 181. Baumann CR, Werth E, Stocker R, Ludwig S, Bassetti CL. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain. 2007;130(Pt 7):1873-83. 182. Nishino S, Kanbayashi T, Fujiki N, Uchino M, Ripley B, Watanabe M, et al. CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies. Neurology. 2003;61(6):823-5. 12

RkJQdWJsaXNoZXIy MjY0ODMw